Aiforia Technologies

3.63

EUR

0 %

AIFORIA

First North Finland

Medical Equipment & Services

Health Care

1,803 following

0%

+3.42%

+3.42%

-0.82%

-19.33%

-1.09%

-27.54%

-

-28.26%

Aiforia Technologies equips pathologists and researchers in preclinical and clinical laboratories with software to translate images into discoveries, decisions and diagnoses. The company's products and services are used for medical image analysis, across a variety of areas from oncology to neuroscience. Aiforia Technologies is headquartered in Finland.

Market cap

105.03M EUR

Turnover

41.99K EUR

P/E (adj.) (24e)

-8.73

EV/EBIT (adj.) (24e)

-8.21

P/B (24e)

6.69

EV/S (24e)

29.44

Dividend yield-% (24e)

-

Coverage

Recommendation

Accumulate

Target price

4.60 EUR

Updated

02.10.2024

Antti Luiro, Frans-Mikael Rostedt

Latest research

Latest analysis report

Released: 03.10.2024

Latest extensive report

Released: 01.03.2024

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

7.3

2025

Annual report '24

4.4

2025

General meeting '25

28.8

2025

Interim report Q2'25

Risk

Business risk

Valuation risk

Low

High

ShowingAll content types

Analyst Comment2/20/2025, 9:45 AM by

Aiforia finally obtained CE certification under the new regulation

Aiforia's CE markings, along with the rest of the industry, have been stuck since the end of May 2022 due to the EU's regulatory change for medical devices (IVDD -> IVDR).

Aiforia Technologies

Press release2/20/2025, 8:30 AM

Aiforia secures IVDR certification, paving the way for expanded clinical portfolio in Europe

Aiforia Technologies

Regulatory press release2/18/2025, 9:15 AM

Share subscriptions based on stock options 2016A

Aiforia Technologies

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Life Science Night | December 9, 2025

Webcast12/9/2025, 2:00 PM

Life Science Night | December 9, 2025

Welcome to follow Life Science Night on Tuesday, December 9 at 4:00 pm EET on inderesTV.

Aiforia Technologies

Aiforia, Webcast, Q4'24

Webcast3/7/2025, 8:00 AM

Aiforia, Webcast, Q4'24

Aiforia Technologies

Press release2/4/2025, 3:30 PM

Aiforia CEO increased shareholding in the company in January

Aiforia Technologies

Analyst Comment1/27/2025, 7:45 AM by

Antti Luiro, Frans-Mikael Rostedt

Aiforia selected as partner for major regional health region in Italy

Aiforia announced that he Lombardy region health authorities in Italy have selected the company as their partner for AI-assisted image analysis for clinical diagnostics in pathology.

Aiforia Technologies

Press release1/24/2025, 1:45 PM

Aiforia selected to provide AI-assisted diagnostic solutions to regional health authorities in Italy

Aiforia Technologies

Regulatory press release1/7/2025, 11:00 AM

Aiforia Technologies Plc – Managers' Transactions

Aiforia Technologies

Regulatory press release12/18/2024, 3:00 PM

Aiforia Technologies Plc – Managers' Transactions

Aiforia Technologies

Aiforia as an Investment | Life Science Night Dec. 2, 2024

Video12/4/2024, 8:00 AM

Aiforia as an Investment | Life Science Night Dec. 2, 2024

Jukka Tapaninen, CEO, talks about medical software company Aiforia as an investment.

Aiforia Technologies

Analyst Comment12/3/2024, 6:52 AM

Life Science Night available on inderesTV

Aiforia Technologies Herantis Pharma Faron Pharmaceuticals

Analyst Comment12/2/2024, 2:55 PM by

Antti Luiro, Frans-Mikael Rostedt

Aiforia wins new clinical segment client in Turkey

Memorial Hospitals Group in Turkey has selected Aiforia as its partner for AI-assisted clinical diagnostics in pathology. Memorial Hospitals Group is the largest private hospital group in Turkey, serving 75,000 patients annually in 11 hospitals.

Aiforia Technologies

Life Science Companies as Investments | Life Science Night Dec. 2, 2024

Video12/2/2024, 2:00 PM

Life Science Companies as Investments | Life Science Night Dec. 2, 2024

Antti Siltanen, Life Science Analyst, PhD, talks about life science companies as investments.

Aiforia Technologies BBS-Bioactive Bone Substitutes Bioretec Biohit Faron Pharmaceuticals Modulight Nexstim Orion Bittium Detection Technology Optomed Revenio Group Nightingale Health Herantis Pharma Nanoform Finland

Life Science Night | December 2, 2024

Webcast12/2/2024, 2:00 PM

Life Science Night | December 2, 2024

Welcome to follow Life Science Night on Monday, December 2 at 4:00 pm EET on inderesTV.

Aiforia Technologies Herantis Pharma Faron Pharmaceuticals

Press release12/2/2024, 12:00 PM

Memorial Hospitals Group in Turkey selects Aiforia as the partner for AI-assisted clinical diagnostics in pathology

Aiforia Technologies

Regulatory press release11/15/2024, 1:30 PM

Aiforia Technologies Plc – Managers' Transactions

Aiforia Technologies

Analyst Comment11/4/2024, 11:06 AM by

Antti Luiro, Frans-Mikael Rostedt

Aiforia enters into new partnership to offer competitor's image analysis models on its own platform

Aiforia announced a strategic partnership with Paige, a competitor developing AI models for pathology. The partnership will make Paige's diagnostic AI applications available on the Aiforia Platform.

Aiforia Technologies

Press release11/4/2024, 7:00 AM

Aiforia and Paige form strategic partnership to advance AI integration in pathology laboratories

Aiforia Technologies

Regulatory press release10/29/2024, 7:00 AM

Aiforia Technologies Plc’s financial reporting and Annual General Meeting in financial year 2025

Aiforia Technologies

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.